|
NL153305B
(nl)
*
|
1969-06-05 |
1977-05-16 |
Philips Nv |
Verwarmingsinstallatie, in het bijzonder geschikt voor voertuigen, voorzien van een heetgasmotor.
|
|
US3717993A
(en)
*
|
1970-11-02 |
1973-02-27 |
Gen Motors Corp |
Preheater assembly for stirling engine
|
|
NL7205878A
(de)
*
|
1972-04-29 |
1973-10-31 |
|
|
|
JPS62116867A
(ja)
*
|
1985-11-16 |
1987-05-28 |
アイシン精機株式会社 |
冷凍装置
|
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
|
US6514530B2
(en)
|
1997-09-09 |
2003-02-04 |
Alza Corporation |
Dosage form comprising means for changing drug delivery shape
|
|
US20040062799A1
(en)
*
|
1997-09-29 |
2004-04-01 |
Ayer Atul D. |
Therapeutic composition and delivery system for administering drug
|
|
DE69805001T2
(de)
|
1997-12-05 |
2002-08-22 |
Alza Corp., Palo Alto |
Osmotische darreichungsform mit zwei mantelschichten
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
RU2241458C2
(ru)
|
1997-12-22 |
2004-12-10 |
Эро-Селтик, С.А. |
Комбинации агонист/антагонист опиоида
|
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
US20010038855A1
(en)
*
|
1998-06-05 |
2001-11-08 |
Desjardin Michael A. |
Dosage form for administering prescribed dose
|
|
EP2263658A1
(de)
|
2000-10-30 |
2010-12-22 |
Euro-Celtique S.A. |
Hydrocodon-Formulierungen mit gesteuerter Freisetzung
|
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
|
ES2361148T3
(es)
|
2001-05-11 |
2011-06-14 |
Endo Pharmaceuticals Inc. |
Forma de dosificación de opioides de liberación controlada resistente al abuso.
|
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
DE20321531U1
(de)
*
|
2002-04-05 |
2007-11-22 |
Euro-Celtique S.A. |
Lagerstabiles pharmazeutisches Präparat, das Oxycodon und Naloxon umfaßt
|
|
KR20060039867A
(ko)
*
|
2003-06-20 |
2006-05-09 |
바이럴 게노믹스, 인크. |
Ｈｉｖ 치료를 위한 조성물 및 방법
|
|
EP1663229B1
(de)
|
2003-09-25 |
2010-04-14 |
Euro-Celtique S.A. |
Pharmazeutische kombinationen von hydrocodon und naltrexon
|
|
TWI483944B
(zh)
*
|
2004-03-30 |
2015-05-11 |
Euro Celtique Sa |
含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
|
EP1604667A1
(de)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioide zur Behandlung des Restless Leg Syndroms
|
|
EP1604666A1
(de)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit
|
|
PT1765292T
(pt)
|
2004-06-12 |
2017-12-29 |
Collegium Pharmaceutical Inc |
Formulações de fármacos dissuasoras de abuso
|
|
AP2274A
(en)
*
|
2005-01-28 |
2011-08-19 |
Euro Celtiques Sa |
Alcohol resistant dosage forms.
|
|
EP1695700A1
(de)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Darreichungsform enthaltend Oxycodon und Naloxon
|
|
EP1702558A1
(de)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Verfahren und Vorrichtung zur Darmtätigkeitserfassung
|
|
EP1813276A1
(de)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Manipulationssichere Dosierformen
|
|
WO2010099508A1
(en)
|
2009-02-26 |
2010-09-02 |
Theraquest Biosciences, Inc. |
Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
|
|
US9271940B2
(en)
|
2009-03-10 |
2016-03-01 |
Purdue Pharma L.P. |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
PT2826467T
(pt)
|
2010-12-22 |
2017-10-25 |
Purdue Pharma Lp |
Formas envolvidas de dosamento de libertação controlada resistentes à adulteração
|
|
PH12013501345A1
(en)
|
2010-12-23 |
2022-10-24 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
|
US20150259355A1
(en)
|
2012-07-16 |
2015-09-17 |
Rhodes Technologies |
Process for improved opioid synthesis
|
|
JP6236447B2
(ja)
|
2012-07-16 |
2017-11-22 |
ローズ テクノロジーズ |
改善されたオピオイド合成方法
|
|
JP6208261B2
(ja)
|
2013-02-05 |
2017-10-04 |
パーデュー、ファーマ、リミテッド、パートナーシップＰｕｒｄｕｅ Ｐｈａｒｍａ Ｌ．Ｐ． |
タンパリング抵抗性医薬製剤
|
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
MX2016000810A
(es)
|
2013-07-23 |
2016-08-05 |
Euro Celtique Sa |
Combinacion de oxicodona y naloxona para su uso en el tratamiento de dolor en pacientes que sufren de dolor y una enfermedad que resulta la disbiosis intestinal y/o aumento del riesgo de la translocacion bacteriana intestinal.
|
|
JP6244035B2
(ja)
|
2014-01-15 |
2017-12-06 |
ローズ テクノロジーズ |
改良されたオキシモルホン合成のための方法
|
|
CN106029670A
(zh)
|
2014-01-15 |
2016-10-12 |
罗德科技公司 |
改进的羟考酮合成的方法
|
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
|
US11181072B2
(en)
*
|
2019-05-21 |
2021-11-23 |
General Electric Company |
Monolithic combustor bodies
|